Deciphering the pharmacological mechanisms of Weiweisu decoction in chronic atrophic gastritis: Insights from network pharmacology, molecular dynamics, and in vivo validation
In summary, WWS decoction can treat CAG through antiferroptosis, and its main mechanism may be related to the regulation of tumor signaling pathways.
Authors
- Hua Chen (ORCID: https://orcid.org/0000-0001-7889-8023)
- Jialin Xu (ORCID: https://orcid.org/0000-0002-3910-1306)
- Sean M. Wu (ORCID: https://orcid.org/0000-0002-0000-3821)
- Yan Dang (ORCID: https://orcid.org/0000-0002-0126-7503)
- Yongcheng Jin (ORCID: https://orcid.org/0000-0002-3462-3674)
- Jie Liu (ORCID: https://orcid.org/0000-0001-6988-5773)
- Xiaoying Zhu (ORCID: https://orcid.org/0009-0007-6003-3989)
- Jialin Shen
- Meng Chen (ORCID: https://orcid.org/0009-0002-8608-1229)
- Caiqun Bie (ORCID: https://orcid.org/0009-0003-0285-9871)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Shaanxi University of Chinese Medicine (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1097/md.0000000000045348
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00